Alembic Pharmaceuticals to raise Rs 500 crore via NCDs

06 Dec 2018 Evaluate

Alembic Pharmaceuticals has received approval to raise funds upto Rs 500 crore through issuance of unsecured listed redeemable Non-Convertible Debentures (NCDs) on private placement basis. The Board of Directors of the company at their meeting held on December 6, 2018, approved the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

961.30 -8.35 (-0.86%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.